MedPath

Nasopharyngeal 24 Hour pH Monitoring in Health Adult Volunteers

Not Applicable
Withdrawn
Conditions
Gastroesophageal Reflux Disease
Registration Number
NCT00584675
Lead Sponsor
University of California, Davis
Brief Summary

Involves a 24-hour pH probe study using the Dx-pH Measurement System on patients who do not have symptoms of laryngopharyngeal reflux or gastroesophageal reflux disease to establish normal values for the Dx-pH Measurement System.

Detailed Description

The specific aim of this study is to establish the normal range of values in an adult population with no symptoms of laryngopharyngeal reflux disease or gastroesophageal reflux disease using the Dx-pH Measurement System.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • 18 years of age or older
  • no symptoms of laryngopharyngeal reflux or gastroesophageal reflux disease
  • score less than 10 on Reflux Symptom Index
Read More
Exclusion Criteria
  • age less than 18
  • known lidocaine allergy
  • history of heartburn, regurgitation, chronic cough, voice changes, globus pharyngeus, excessive throat clearing, or swallowing problems
  • score 10 or greater on Reflux Symptom Index
  • current or past antacid use or other antireflux therapy
  • history of antireflux surgery
  • pregnancy
  • current anticoagulation therapy (warfarin, heparin, aspirin, clopidogrel bisulfate)
  • special/vulnerable populations (children, mentally handicapped, pregnant women, fetuses, prisoners, cognitive impairment, life-threatening disease, social or economic disadvantage)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
To develop a range of normal values in adults without symptoms of laryngopharyngeal reflux.At completion of study
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of California Davis Medical Center

🇺🇸

Sacramento, California, United States

© Copyright 2025. All Rights Reserved by MedPath